GALVANI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 196
AS - Asia 52
NA - Nord America 51
AF - Africa 3
Totale 302
Nazione #
IT - Italia 167
US - Stati Uniti d'America 51
CN - Cina 26
SG - Singapore 17
IN - India 8
ES - Italia 6
GB - Regno Unito 6
IE - Irlanda 4
CI - Costa d'Avorio 3
DE - Germania 3
AT - Austria 2
FR - Francia 2
NL - Olanda 2
SE - Svezia 2
FI - Finlandia 1
PK - Pakistan 1
PL - Polonia 1
Totale 302
Città #
Parma 38
Milan 31
Ashburn 17
Shanghai 12
Boardman 9
New York 8
Weihai 8
Bologna 6
Singapore 6
Brescia 5
Canneto sull'Oglio 5
Madrid 5
Palermo 5
Piacenza 5
Delhi 4
Dublin 4
Guangzhou 4
London 4
Salsomaggiore Terme 4
Abidjan 3
Castellarano 3
Cesano Maderno 3
Coimbatore 3
Naples 3
Amsterdam 2
Beijing 2
Caprino Veronese 2
Casalnuovo di Napoli 2
Castiglione Olona 2
Chiari 2
Ferrara di Monte Baldo 2
Genoa 2
Modena 2
Ospitaletto 2
Pomigliano d'Arco 2
Reggio Emilia 2
Rocca Grimalda 2
Romainville 2
Salerno 2
Sesto San Giovanni 2
Taranto 2
Vignola 2
Aulla 1
Bremen 1
Castelló de la Plana 1
Cleveland 1
Council Bluffs 1
Dorking 1
Düsseldorf 1
Frankfurt am Main 1
Fumane 1
Gossolengo 1
Helsinki 1
Hyderabad 1
Innsbruck 1
Karachi 1
Lubbock 1
Neviano degli Arduini 1
Oxford 1
Padova 1
Pancarana 1
Quattro Castella 1
Seattle 1
Tappahannock 1
Terni 1
Torun 1
Verona 1
Vienna 1
Totale 257
Nome #
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 70
Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents 54
Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency 50
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines 42
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 40
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 22
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations 18
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 15
Totale 311
Categoria #
all - tutte 1.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202359 0 0 0 0 3 3 0 1 12 10 21 9
2023/2024229 13 10 12 11 16 23 7 17 10 18 52 40
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 311